ASX - By Stock
|
PAR |
Re:
Mesoblast
|
|
mp28
|
10 |
3.7K |
17 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
10
|
3.7K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Over PAR
|
|
mp28
|
49 |
18K |
1 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
49
|
18K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
mp28
|
4.4K |
2.0M |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
mp28
|
4.4K |
2.0M |
3 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
mp28
|
4.4K |
2.0M |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
mp28
|
4.4K |
2.0M |
4 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
4
|
|
ASX - By Stock
|
PAR Medicine |
Re:
LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review
|
|
mp28
|
16 |
9.6K |
9 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
16
|
9.6K
|
9
|
|
ASX - By Stock
|
PAR Medicine |
Re:
LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review
|
|
mp28
|
16 |
9.6K |
1 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
16
|
9.6K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
mp28
|
4.4K |
2.0M |
6 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
The (Painful) Competition
|
|
mp28
|
13 |
4.8K |
0 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
13
|
4.8K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
The (Painful) Competition
|
|
mp28
|
13 |
4.8K |
1 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
13
|
4.8K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day 2024 - scurvy dogs o' the ASX
|
|
mp28
|
111 |
34K |
0 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
111
|
34K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
mp28
|
4.4K |
2.0M |
7 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
7
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
mp28
|
4.4K |
2.0M |
1 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
mp28
|
4.4K |
2.0M |
3 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
New Player
|
|
mp28
|
81 |
21K |
0 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
81
|
21K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
mp28
|
4.2K |
3.8M |
4 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
The Determination
|
|
mp28
|
20 |
9.7K |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
20
|
9.7K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
mp28
|
4.4K |
2.0M |
14 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
14
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
6 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
706
|
255K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
0 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
706
|
255K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
7 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
706
|
255K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mp28
|
34 |
19K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
34
|
19K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mp28
|
34 |
19K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
34
|
19K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mp28
|
34 |
19K |
20 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
34
|
19K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
706
|
255K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
706
|
255K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
706
|
255K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
706
|
255K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
13 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
706
|
255K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
8 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
706
|
255K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
706
|
255K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
706
|
255K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
706
|
255K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
706
|
255K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
mp28
|
706 |
255K |
3 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
706
|
255K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
mp28
|
670 |
261K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
670
|
261K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
mp28
|
54 |
18K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
54
|
18K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
mp28
|
75 |
26K |
8 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
75
|
26K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
mp28
|
75 |
26K |
2 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
75
|
26K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
mp28
|
75 |
26K |
3 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
75
|
26K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
mp28
|
75 |
26K |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
75
|
26K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
mp28
|
75 |
26K |
2 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
75
|
26K
|
2
|
|
ASX - By Stock
|
JAV |
Re:
Ann: Voluntary Suspension
|
|
mp28
|
52 |
21K |
0 |
02/12/19 |
02/12/19 |
ASX - By Stock
|
52
|
21K
|
0
|
|
ASX - By Stock
|
JAV |
Re:
Ann: Voluntary Suspension
|
|
mp28
|
52 |
21K |
1 |
29/11/19 |
29/11/19 |
ASX - By Stock
|
52
|
21K
|
1
|
|
ASX - By Stock
|
JAV |
Re:
Ann: Malamute Drilling To Commence
|
|
mp28
|
28 |
14K |
1 |
20/11/19 |
20/11/19 |
ASX - By Stock
|
28
|
14K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR - Conference Call Details - Phase 2b OA Results
|
|
mp28
|
26 |
9.7K |
3 |
18/12/18 |
18/12/18 |
ASX - By Stock
|
26
|
9.7K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR - Conference Call Details - Phase 2b OA Results
|
|
mp28
|
26 |
9.7K |
3 |
17/12/18 |
17/12/18 |
ASX - By Stock
|
26
|
9.7K
|
3
|
|
ASX - By Stock
|
RRS |
Re:
Ann: Voluntary Suspension
|
|
mp28
|
14 |
3.5K |
0 |
10/12/18 |
10/12/18 |
ASX - By Stock
|
14
|
3.5K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Fifty One Capital updated report
|
|
mp28
|
71 |
33K |
6 |
27/11/18 |
27/11/18 |
ASX - By Stock
|
71
|
33K
|
6
|
|